Аналитика Telegram-канала
Подписчики
36
Охват за 24 ч
12
ER за 24 ч
33,33%
Публикаций
38

Динамика подписчиков

7 дней 30 дней 6 месяцев Больше
11 ноя14 ноя17 ноя
Показаны последние 7 дней Больше истории →

Охваты публикаций

09.1110.1110.1110.1111.1116.11
2
Средний охват
4
Лучший результат
Показаны 6 публикаций — последние в канале Больше статистики →

Упоминания

2
Упоминаний
0
Из них репостов
1
Каналов
Все упоминания

Последние посты

3 из 38 2 из 38
Фото
Anthropic IPO. From 100 USDT. Fintch now offers access to the Anthropic IPO at an indicative price of $70–78 per share, through our new on-chain app. The updated infrastructure makes the investment process more transparent and verifiable, from subscription to settlement. Anthropic deal terms: • Indicative IPO price: $70–78/share • Minimum participation: 100 USDT • Subscription closes November 18 • Allocation is not guaranteed • Unallocated funds are refunded • 5% entry fee / 20% success fee • 93-day post-IPO lock-up Secondary trading is coming. We're working on a secondary market that will allow participants to offer their positions for sale before final settlement, subject to buyer availability. Explore the deal: https://pro.fintch.one/markets/anthropic
ещё
1 0 16 ноя, 16:09
Фото
🧠 Anthropic IPO: the countdown begins $70–78 per share. An expected November 19 debut. A valuation around $1 trillion. We previously shared access to Anthropic through Fintch. Now the company behind Claude has launched its IPO roadshow and announced its indicative price range — bringing its Nasdaq debut another step closer. Trading is expected to begin on November 19, subject to change. At roughly $1 trillion on a basic-share basis, the question is not just how fast AI adoption can grow — but how much of that growth is already priced in. Participation through Fintch: • Minimum investment: 100 USDT • Lock-up period: 93 days 📅 Deadline: November 18, 2026. 📲 Explore Anthropic in Market and submit your application: Download
ещё
1 0 11 ноя, 12:11
Фото
🦷 New IPO: vVARDIS Holding A new IPO opportunity is coming to the Fintch app. Treat early tooth decay without the drill. Swiss dental technology company vVARDIS is building its business around that approach. Its Curodont platform uses self-assembling peptides to support enamel remineralization. Treatment takes approximately five minutes, without drilling or injections. It has already been used on more than 3.5 million teeth and supplied to over 20,000 US dental practices. Bet on: growing adoption of minimally invasive dentistry + rapid commercial growth. First-half 2026 revenue rose 214.2% to $28.6M. Henry Schein provides exclusive US distribution, while Apollo backs the company. Adoption is growing, but the price demands execution. The proposed $4.1B valuation represents approximately 82x trailing revenue. vVARDIS remains loss-making and depends heavily on one flagship product and its US distribution partner. 📊 Key terms & financials - Indicative price: $21.00-24.00 per share - IPO valuation: approximately $4.1B - Target IPO proceeds: $214.3M - Revenue: $49.7M for the 12 months ended June 30, 2026 - Net loss: $52.2M over the same period - H1 2026 revenue: $28.6M (+214.2% YoY) - Ticker: VVVV - Expected listing: November 13, 2026 | NYSE - Lock-up period: 93 days - Minimum investment: 100 USDT Expected upside: 20% (not guaranteed) 📅 Deadline:: November 12, 2026. 📲 Explore the deal in the Fintch app: Download
ещё
2 0 10 ноя, 19:59
Больше постов

Продолжить анализ этого канала

  • История роста подписчиков
  • Просмотры и охваты публикаций
  • Кто упоминает канал и кого упоминает он
  • Похожие каналы и подбор для рекламы
Открыть аналитику
Демо до 14 дней